中文 | English
Return
Total: 333 , 1/34
Show Home Prev Next End page: GO
MeSH:(*Ophthalmic Solutions)

1.Establishing the formulation of 0.1% diclofenac eye drops

Hoang Ngoc Hung

Pharmaceutical Journal 2005;0(12):17-20

2.optimization of tobramycine 0.3% ophthalmic formulation

Hoang Ngoc Hung

Pharmaceutical Journal 2005;354(10):13-16

3.The influence of packaging materials and stocking conditions on the stability of eye drop containing vitamin B5

Hoang Ngoc Hung

Journal of Medical and Pharmaceutical Information 2003;0(5):21-23

5.Study on some factors influencing on the stability of tobramycin 0.3% eye drops

Tran Thi Minh Thu

Pharmaceutical Journal 2005;0(7):19-23

6.The Additive Effect of Trusopt to Beta-blockers in the Treatment of Glaucoma Patients.

Kyoung Seob LEE ; Gong Je SEONG

Journal of the Korean Ophthalmological Society 1998;39(2):369-374

7.The Therapeutic Effects of Early Administration of 5%Na Cl Eye Drops on Corneal Edema Induced by Intracameral Injection of 2%Lidocaine in Rabbits.

Yeoun Sook CHUN ; Jeong Hun KIM ; In Ki PARK ; Won Ryang WEE ; Jin Hak LEE

Journal of the Korean Ophthalmological Society 2000;41(9):1883-1890

8.Preparation of Autologous Serum Eye Drops.

Hyunsoo KIM ; Jekwang LEE ; Eun Kyung LEE ; Hyunjin NAH ; Hyun Ok KIM

Korean Journal of Blood Transfusion 2018;29(1):68-72

9.Bacteria-Filtering Effect of a Filtering System Used in Eye Drops.

Kyun Hyung KIM ; Jaeryung OH ; Joon Heon KIM ; Hyo Myung KIM

Journal of the Korean Ophthalmological Society 2007;48(10):1329-1334

10.Study on the Effectivity and Stability of the Fortified Ophthalmic Solutions.

Jai Bong KIM ; Sang Ki JEONG ; Yeoung Geol PARK ; Phil Youl RYU

Journal of the Korean Ophthalmological Society 1993;34(5):468-473

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 333 , 1/34 Show Home Prev Next End page: GO